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Abstract 
The development of completely defined, serum-free media is of 
importance to the study of the physiology of cultured cells. In 
this study, experiments aimed at developing a completely defined 
medium suitable for growth of a human retinoblastoma tumor cell 
line (Y-79) in culture were conducted. Specifically, the ability 
of four trace metals to enhance Y-79 cell growth was studied in 
serum-free medium. Addition of either cobalt, copper, chromium or 
selenium to a standard, serum-free medium (RPMX-1640) did not 
stimulate Y-79 cell growth. 
Previous studies of the Y-79 cell line have demonstrated that 
addition of apotransferrin (3 ug/ml) to the culture medium enhances 
growth of Y-79 cells. Therefore, the ability of these trace metals 
to further stimulate growth in the presence of apotransferrin 
enriched medium was examined. While chromium, copper or cobalt did 
not increase cell number, selenium (3x10 -10 molar) did 
potentiate cell growth when added to apotransferrin enriched 
medium. Therefore, selenium and transferrin must act synergisti- 
cally. The establishment of improved growth conditions for Y-79 
cells in synthetic medium should aid in further studies of the 
physiology of both malignent and normal retinal cells. 
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Introduction 
The development of completely defined, serum-free media is 
crucial to the successful analysis of the chemical nature of 
cultured cells and of the metabolites and products they excrete. 
Completely synthetic media are also important in determining the 
mechanism of action of certain factors on cultured cells. In this 
study, we investigated the effects of various metal ions on the 
growth of Y-79 cells in serum-free culture. This cell line derives 
from a human retinoblastoma tumor established in culture in this 
lab over a decade ago.(48) 
Our rationale for this work came from the observation that 
conditioned media from Y-79 cells could support the growth of other 
untransformed retinal tissue which could not easily be grown in 
culture otherwise. Unfortunately, optimum growth of Y-79 cells 
required the addition of fetal calf serum to the medium. The 
presence of serum made it extremely difficult to isolate the growth 
factor, which we presumed was synthesized by Y-79 cells, enabling 
other neuronal tissue to grow in culture. The task became one of 
discovering a completely defined medium which would optimally 
support the growth of Y-79 cells and thereby yield conditioned 
medium from which we could hope to isolate a true nerve growth 
factor. This purified growth factor might allow us to grow and 
examine normal retinal cells in culture. Also, we hoped that, by 
elucidating the growth requirements of transformed retinal cells, 
i*e. Y-79 cells, we could more closely approximate the growth needs 
of normal retinal tissue and eventually come to a fuller under¬ 
standing of the normal physiology of the retina. 
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Role of Selenium in tissue culture 
Work by Ham in Colorado indicated that trace metals play a 
major role in enabling cells to grow in culture. In his efforts to 
develop a protein-free medium, he found that Chinese Hamster ovary 
_8 
and lung lines require 10 -10 M selenium (given as ^SeO^) for 
optimum growth (22). He discovered the cells' need for Selenium 
(Se) when he moved his lab to Boulder, Colorado and could not 
achieve cell growth with his protein-free medium (F-12) developed 
elsewhere (19). He eventually noticed that adding Se and/or 
L-thyroxine restored growth. Upon assaying the L-thyroxine for its 
Se content, present as a contaminant, he discovered that the Se 
alone accounted for all the observed stimulation (22). McKeehan 
et al. have also established Se as essential to the growth of 
human fetal lung cells in culture at an optimum concentration of 
—8 3x10 M (36). The exact reasons for this Se effect are 
uncertain as the essential role of Se in biological systems has 
only recently been recognized. 
Se, a group VI element under sulfur in the periodic table, was 
discovered by Berzalius in 1817, but for many years, few Se 
compounds were investigated. In the 1930's, Se was identified as a 
toxin in animals and extensively investigated as the cause of such 
animal diseases as "Blind Staggers" and "Alkali Disease" (39). 
However, only in the last 20 years has Se been shown to be an 
essential nutrient for many animals and bacteria. In 1957, Se was 
identified as the essential substance in Factor 3, an uncharacter¬ 
ized dietary supplement, which protected rats from severe necrotic 
degeneration of the liver (56). This observation soon led other 
researchers to demonstrate Se responsive diseases in over 40 
_ 
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species (6,36) including White Muscle Disease in lambs and calves 
(44), exudative diathesis in chicks and turkeys (59), and necrotic 
liver degeneration in rats and swine (56,9). However, to date, no 
human disease secondary to Se deficiency has been well documented 
although Keshan disease, a fatal cardiomyopathy of children 
occurring in a region of China where environmental Se levels are 
very low, is thought to be related to inadequate Se intake (72). 
Also, one case, resulting from prolonged total parenteral 
nutrition, has been reported recently (31). This dearth of people 
suffering from Se deficiency may perhaps be explained by the fact 
that most people ingest food from several geographic regions and, 
therefore, usually have no difficulty in consuming the presumed 
daily requirement of 0.75 ueqs (59). 
In the last 10 years, advances have been made in the 
elucidation of the role of Se in biochemical processes. Several 
enzymes have been found to contain Se. Stadtman has elucidated 
two bacterial selenoenzymes, formate dehydrogenase and glycine 
reductase (59), and three other bacterial enzymes, nicotinic acid 
hydroxylase, xanthine dehydrogenase, and thiolase have recently 
been identified as likely selenoenzymes (60). In ovine heart and 
skeletal muscle, Se is incorporated into a 20,000 MW hemoprotein 
very similar in structure to cytochrome C. This protein is absent 
in the tissue of Se deficient animals suffering from White Muscle 
Disease (70). Finally, Se has been discovered to be an integral 
component of the enzyme glutathione peroxidase, (glutathione: 
hydrogen peroxide oxidoreductase, EC 1.11.1.9), abbreviated GSH-Px, 
isolated from many species, including human tissue. 
GSH-Px catalyzes the reaction, ROOH + 2GSH —* ROH + GSSG + 
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H2O where ROOH can be any of a variety of hydroperoxides and ROH, 
its corresponding alcohol. GSH is reduced glutathione: GSSG is 
oxidized glutathione (73). This enzyme protects cells against 
oxidant damage by reducing many different hydroperoxide substrates, 
including H2O2, at rates comparable to reduction of H2O2 by 
catalase (15). However, the enzyme is highly specific for GSH as a 
donor substrate and it will not catalyze the breakdown of 
hydroperoxides in the presence of other physiological hydrogen 
donors (60), except for one study indicating substantial reduction 
of linoleic acid peroxide by liver GSH-Px using cysteine and 
cysteamine as hydrogen donors (34). 
GSH-Px was first reported present in rat and bovine erythro- 
ocytes in 1957 by Mills who noted that it protected erythrocytes 
from hemoglobin oxidation and hemolysis (43). Later, it was found 
that erythrocytes could be protected from hemolysis by adding 
glucose to the incubation medium. The presumed mechanism was that 
glucose maintained GSH levels (via the hexose monophosphate shunt) 
and thus, provided GSH-Px with a reducing substrate (60). Rotruck 
et al. discovered the connection between GSH and Se in 1971 when 
they observed that the protection from hemolysis afforded by the 
addition of glucose to the incubation medium was markedly decreased 
in erythrocytes from Se deficient rats (52). In 1973, Rotruck 
et al. identified GSH-Px as a selenoenzyme (70). 
GSH-Px is an enzyme with a MW of about 80,000 although it 
varies somewhat from species to species and from tissue to tissue 
within the same species (15). It was first described in 
erythrocytes but has since been documented in many other cell 
types. Tissues highest in GSH-Px include liver, phagocytic cells, 
. 
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and erythrocytes. Intermediate levels are found in heart, lung, 
kidney, adrenal gland, stomach mucosa, pancreas and adipose tissue. 
Low levels have been noted in brain, lens, testis, skeletal muscle, 
aorta and uterus (15). The subcellular localization of GSH-Px has 
indicated activity in both the cytosol and mitochondrial fractions 
where it is thought to protect the outer and inner mitochondrial 
membranes respectively from oxidation (15). 
Enzyme studies using tissue from several different species 
indicate that the molecule is constructed of four identical 
subunits (MW=22,000) and contains four gram atoms of Se per mole of 
enzyme (46,11,12,60). It contains no heme, flavin or other metals 
as indicated by the gamma spectrum of the irradiated enzyme (12) 
and therefore, differs from all other known peroxidases. Zakowski 
et al. have recently shown that Se is present in the active site 
of the reduced enzyme in the form of selenocysteine and have 
proven, by sequential Edman degradation, that the selenocysteine is 
located within the polypeptide chain (73). 
The kinetic mechanism of GSH-Px has been described by Ganther 
et al. as a series of three bimolecular steps (14,36) where Se 
participates in a set of redox reactions at the active site as 
follows: 1) The active site selenol(E-SeH) undergoes oxidation 
with peroxide to form a selenenic acid (E-Se-OH). 2) The oxidized 
form of the enzyme reacts with the first GSH molecule, forming a 
mixed selenosulfide (E-Se-SG) and a molecule of H£0. 3) The 
selenosulfide linkage is cleaved by a second GSH molecule, 
producing oxidized glutathione and restoring the enzyme to the 
selenol form. An analogous set of reactions can be written in 
which Se cycles between selenenic (E-Se-OH) and seleninic 
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(E-Se-02H) forms. There is some evidence for the presence of 
different oxo-derivatives of Se during catalysis, but none of these 
oxidation states has been conclusively identified in the native 
molecule (15). 
The activity of GSH-Px in vivo depends on the presence of Se. 
Animals maintained on Se deficient diets show rapid increases in 
enzyme activity when Se is reinstituted into their diets (69). 
Investigators working with cultured cells where Se has been found 
to be an essential nutrient have speculated that the growth 
enhancing action of Se may be due to its incorporation into the 
selenoenzyme, GSH-Px (36,18). More recently, Germain and Arneson 
have ascertained that the activity of GSH-Px in cultured mouse 
neuroblastoma cells is directly proportional to the concentration 
—8 
of selenite in the medium below 6x10 M and levels off at 
concentations above this value (16). This concentration is similar 
to the optimum concentrations found for growth enhancement in other 
tissue culture work (22,2,36). Thus, the growth enhancing effects 
of Se may very well be secondary to its stimulation of GSH-Px 
synthesis and/or activity leading to protection of vital cell 
components from oxidation. In fact, requirements for Se in tissue 
culture of diploid human fibroblasts have been found to be 
quantitatively lower when cells are grown at lower oxygen 
concentrations (37). Also, the inhibitory effects of excess oxygen 
are much more severe when cells are marginally deficient in Se than 
when adequate amounts are supplied (20). 
Role of Transferrin in Tissue Culture 
Our lab has also noted recently that apotransferrin, in an 
• • —8 
optimum concentration of 3 ug/ml (3x10 °M), will support the 
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growth of Y-79 cells in iron-free and serum-free medium 
(RPMI-1640). This cell line is unusual because no additional 
hormones or growth factors are necessary to support growth. Many 
labs have found that transferrin enhances growth in a variety of 
serum-free tissue culture systems but most have required at least 
insulin (24,4), and usually other growth factors as well, to 
sustain the cells in culture (54,41,7,10,24,49,13,55,68,45). 
Transferrin is a serum protein, a B globulin, with a 
MW=77,000. It has a single peptide chain with 2 metal binding 
sites which in the past were thought to be very similar (23). 
However, the current notion of transferrin binding is that the A 
site binds most of the iron at physiological pH's and delivers the 
iron used by erythrocyte precursors and the placenta. The B site, 
employed only during situations of iron excess, carries iron to the 
hepatocytes (Fletcher-Huehns hypothesis) (5). 
Very recently, investigators have noted the presence of 
specific receptors for transferrin on transformed cells. Galbraith 
et al. examined 18 human cell lines, including 25 transformed 
cell lines of malignant and lymphoblastoid origin, for their 
ability to bind transferrin. Less than 5% of normal cells 
(peripheral blood mononuclear cells and cultured diploid 
fibroblasts) exhibited membrane binding of transferrin whereas over 
80% of the transformed cell lines demonstrated specific receptors 
for transferrin (13), Faulk et al. immunohistologically examined 
the breast tissue from 59 patients and determined that almost none 
(1/37) of the tissue from normal areas or benign lesions and 72.7% 
of the malignant specimens were positive for the presence of a 
transferrin receptor (10). This receptor will bind apotransferrin 
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as well as saturated transferrin whereas receptors found on normal 
erythrocyte precursors hardly bind apotransferrin, at all. 
Receptors with identical specificity have also been found on normal 
trophoblast membrane at the maternofetal interface (10). These 
authors conjecture that the trophoblast and the tumor may benefit 
from derepression of receptor synthesis for either nutritional 
reasons, lymphocyte modulation or escape from immunosurveillance in 
a manner similar to the schistosome (13). 
The most obvious explanation for the increased binding of 
transferrin by transformed and malignant cells is a nutritional 
one. These rapidly growing cells probably have an increased 
requirement for the iron complexed with transferrin. For example, 
iron has been shown to be necessary for DNA synthesis and mitosis 
in HeLa cell culture (50) as well as cell division in cultured 3T6 
cells (54). Immature leukemic cells from patients with acute 
leukemia will take up radioiron whereas leukocytes from healthy 
volunteers lack this ability (7). Iron may also be necessary for 
the synthesis of the electron transport chain and/or the synthesis 
of enzymes involved in the oxidation and reduction of critical cell 
products such as cis-unsaturated fatty acids and nucleic acid 
precursors (71). Interestingly, GSH-Px activity in erythrocytes is 
determined by the availability of iron during development in the 
bone marrow. In blood drawn during the induction of iron 
deficiency, younger cells had decreased enzyme activity compared to 
older cells. However, as iron deficient animals were refed iron, 
younger cells had higher enzyme activity than did older erythro¬ 
cytes (51). Therefore, perhaps Y-79 and other cells exhibit 
increased growth in the presence of transferrin simply because of 
I ' ■ 
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their increased iron requirements. 
However, the physiological situation is probably more complex, 
especially since transferrin enhances Y-79 cell growth in the 
apparent absence of iron. The reports, cited above, indicating 
that transferrin is one of a small number of proteins and growth 
factors necessary to support the serum-free growth of embryonal 
cancer cells, HeLa cells, B lymphocytes, BHK cells and 3T3 cells, 
suggest that transferrin may have other important roles in the 
physiology of many cells, a role poorly understood at the present 
time. Other facts about transferrin have emerged which support the 
concept of a wider importance for this protein. Besides its growth 
stimulating action, transferrin has been noted to have an 
antimicrobial action (5) as well as increasing the mitogenic 
response to phytohemagglutinin (PHA) in human lymphocytes. This 
enhancement of the PHA effect at 4-5 ug/ml of transferrin could not 
be reproduced by free iron salts (FeCl3 at 10-^-10_^M) 
(66). Whatever the mechanism underlying the growth enhancing 
effect of transferrin, one is tempted to speculate that its in 
vitro action may be similar to its in vivo role since their 
effective concentrations are similar. 
Transferrin is also known to bind many other metals besides 
iron (23,65) and a specific receptor for zinc, bound to 
transferrin, has been observed in human lyumphocytes (47). While 
Se is known to bind to alpha2 and beta globulins and especially 
beta lipoprotein (6), it has not been shown to bind to transferrin. 
However, several investigators have used Se and transferrin in 
combination and found that these agents, plus other factors, could 
partially or completely replace serum, depending on the cell line 
■ 
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(18,30,29,4,41,44,37). Guilbert and Iscove noted serum sparing 
effects (from 30% to 2.5% fetal calf serum) in haematopoietic cell 
cultures grown in medium containing selenite (10”7M), trans¬ 
ferrin (3.4xlO”^M), albumin and lecithin (18). Iscove and 
Melchors found that murine B lymphocytes grew and matured into IgM 
and IgG secreting cells in serum-free culture medium containing 
—8 -7 
transferrin (10 M), Se (10 'M), albumin and soybean 
lipid. Their data are difficult to interpret because the soybean 
lipid used was a crude lecithin preparation (30). Hutchings and 
Sato developed a serum-free medium, that would support HeLa cells, 
containing transferrin (5xlO"^M), Se (1.5xlO”®M), as well 
as insulin, aldosterone, epidermal growth factor and fibroblast 
growth factor (29). Breitman et al. reported the growth and 
differenciation of human promyelocytic cells in a culture medium 
—8 —8 
containing Se (3x10 M), transferrin (5x10 M) and insulin 
(4). Therefore, we felt it would be of interest to examine the 
effects of transferrin and Se, in concert, on our Y-79 
retinoblastoma cell line. 
Other Trace Metals 
Chromium, copper and cobalt are other trace metals known to be 
essential in biochemical processes (39). Chromium is important for 
the maintenance of normal glucose tolerance (40) and at least one 
group has found it to enhance growth in a Chinese hamster cell line 
in a concentration of 10“9M (22). Copper, essential-for many 
oxidative enzymes as well as for the effective utilization of iron, 
has also had growth stimulating effects in vitro 
(10"7-10"9M) on human diploid fibroblasts and fetal lung 
cells (37), on Chinese hamster cell lines (22,27,19), and NCTC 
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Clone 929 Strain L cells (13). It was also present as a 
"contaminant" (.05 mg/L) in Takaota's studies on mouse fibroblasts, 
HeLa cells, monkey kidney cells, rate ascites hepatoma cells, rat 
thymus reticulum cells, and rat liver parenchymal cells (62,20). 
Cobalt is an important requirement for the activity of several 
enzymes, including ribonucleotide reductase and glutamate mutase, 
as well as for Vitamin dependent processes. Ham has found it 
helpful in tissue culture of Chinese hamster cells at concentra- 
tions of 10”^M (22). All of these metals are known to bind to 
transferrin (23) although iron will displace them if present (5). 
Therefore, we decided to examine the effects of the trace metals, 
copper, cobalt, chromium and selenium on the growth of Y-79 cells 
by testing them alone and in the presence of an optimum 
concentration of apotransferrin. 
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Materials and Methods 
Cells and Materials 
The Y-79 human retinoblastoma tumor cell line used in these 
studies has been in continuous cell culture in our laboratory since 
its establishment in 1971 after removal from the eye of a 2-1/2 
year old white girl (48). 
Components of the medium were obtained as follows: RPMI-1640 
from Flow Laboratories; fetal bovine serum from Gibco; sodium 
selenite (Na2Se03) from Alfa Division, Ventron Corporation; 
cobalt chloride (CoCl2*6H20) from Fisher; Chromium chloride 
(CrCl3*6H20) and copper sulfate (CuSC>4*5H20) from 
J.T. Baker. Bovine albumin (fatty acid free) and Human 
Apotransferrin (pfs) were obtained from Sigma. The antibiotics 
penicillin (10,000 u/ml) and streptomycin (10,000 ug/ml) were 
purchased as lOOx concentrated solutions in physiological saline 
from Grand Island Biological Company. RPMI-1640 is dissolved in 
deionized, doubly distilled water prepared in our laboratory. 
Maintenance of Y-79 Cell Culture 
The Y-79 stock cell cultures were maintained in RPMI-1640 
supplemented with 5% fetal bovine serum, 3xl0~®M Na2Se03, 
100 u/ml of penicillin, 100 ug/ml of streptomycin and .01 M HEPES 
(N-2-hydroxyethyIpiperazine-N"-2-ethane sulfonic acid). They were 
grown in suspension in 150 ml flasks (Costar) in a total volume of 
approximately 75 ml at 37°C in a moist atmosphere of 95% air 
and 5% CO2. The cultures were fed twice weekly and split as 
needed. During feeding, approximately 10 ml of the depleted medium 
were left in the flasks. 
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Growth Experiments . 
Y-79 cells were spun down in 50 ml centrifuge tubes (Corning) 
and washed once in serum-free medium. They were resuspended by 
vigorous pipetting and a 0.5 ml sample was counted by Coulter 
Counter (standardized periodically with a hemacytometer count of 
cells treated with trypan blue). Cells were then divided, spun 
down in 15 ml centrifuge tubes (Corning), and brought up in the 
various experimental media. (The experimental media consisted of 
RPMI-1640, penicillin (100 u/ml), streptomycin (100 ug/ml), HEPES 
(.01M) and varying concentrations of cobalt chloride, sodium 
selenite, copper sulfate, or chromium chloride, with and without 
the addition of 3 ug/ml of apotransferrin as explained in the 
results.) These cells were then divided into 16x125 mm tissue 
culture tubes (Corning) in 1 ml aliquots with a projected final 
cell concentration of 5x105 cells/ml, and 0.5 ml of the residual 
cells in the various media were counted as below to verify cell 
number. The tissue culture tubes were slanted at 5° and 
incubated at 37°C in a moist atmosphere of 95% air and 5% 
CO2. Cells were fed on day 4 by the following procedure: 5 ml 
of fresh medium were added to each tissue culture tube and the 
cells were spun down. 5 ml of medium was then evacuated, leaving 1 
ml of medium into which the pellet was resuspended. 
Counting Procedure and Data Analysis 
Two tubes were randomly selected for counting on days 1,2,4, 
and 7. 1-1/2 hours prior to counting, bovine serum albumin was 
added to each sample (1 mg/ml) because this procedure was found to 
ensure uniformity of cell size before counting with the Coulter 
Counter. Each 1 ml sample was diluted with isotonic buffered 
' 
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saline (Scientific Products) and counted twice on the Coulter 
Counter and the results corrected and averaged. Standard 
deviations were computed for each data point. In some cases, data 
were represented as a ratio of cell number at day 4 (A) to cell 
number at day 1 (B) in order to standardize for differences in 
initial cell concentration. The error of this ratio was computed 
via the following formula and the errors averaged. 
S(j(A/B) = y 1/B2(var A) + A2/B^(var B) 
Day 1, and not day 0, was chosen as the denominator for this ratio 
because the counting procedure for day 0 differed from that of day 
1 through day 7 in number of samples averaged as well as aliquot 
size. In one instance, noted in the results, the ratio of cell 
number at day 3 to cell number at day 1 was used. 
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Results 
I. Effect of Trace Metals on Y-79 cell growth in the Absence of 
Apotransferrin 
In order to determine the effect of the addition of cobalt, 
copper, chromium, and selenium ions on the growth of Y-79 cells in 
culture, a variety of concentrations of each metal were tested. 
Figure 1 illustrates the seven day growth curve of Y-79 cells in 
concentrations of C0CI2 ranging from 10-^-10~^M. In 
Figure 2, the ratio of cell number at day 4 to cell number at day 1 
is shown. In comparison to the cells grown in RPMI-1640 without 
CoCl2 added, there does not appear to be any enhancement of 
growth. Indeed, at each concentration of C0CI2 tested, growth 
lagged behind that of the control cells. As expected, cells 
maintained in medium enriched with 5% fetal bovine serum 
outstripped all other groups in growth between day 1 and day 4. 
Figure 3 and 4 show comparable results for CUSO4 in 
concentrations ranging from 10 -10 M. There was no 
enhancement of Y-79 cell growth when this metal was added to the 
medium. 
The results found when CrCl3 was added, in concentrations of 
10~10-10"7M, are displayed in Figures 5 and 6. No signi¬ 
ficant enhancement of growth was noted at any of the concentrations 
tested. Similarly, at 10”^- 3xlO~^M Na2Se03, growth 
increments between day 1 and day 4 did not differ significantly 
from controls (Figures 7 and 8). 
II. Effect of Trace Metals on Y-79 Cell growth in The Presence of 
Apotransferrin 
Consistent with results found previously in our laboratory 
(unpublished), the addition of 3 ug/ml of apotransferrin to the 
. 
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culture medium resulted in a reproducible enhancement of growth. 
For example, as illustrated in Figure 10, cells grown in 
apotransferrin-enriched medium grew better than control cells. 
However, growth of these cells was surpassed by that of cells grown 
in medium supplemented with 5% fetal bovine serum. In order to 
determine whether the addition of trace metals could lessen this 
discrepency, the effects of cobalt, copper, chromium and selenium 
were ascertained in the presence of apotransferrin. 
Figure 9 presents the four day growth curves of cells grown in 
the presence of 10 ^ - 10 C0CI2 as well as growth 
curves of control cells grown in either serum-free medium, 
serum-free medium plus apotransferrin or serum-enriched medium. 
Figure 10 illustrates the ratio of cell number at day 4 to cell 
number at day 1. When this ratio is used as a measure of growth, 
it becomes apparent that the addition of C0CI2 does not alter the 
enhancement of cell growth rate produced by apotransferrin. 
Figures 11 and 12 present comparable data for concentrations 
of CUSO4 ranging from 10“^- 10“^M. Although 10“^M 
CUSO4 appears to enhance growth above the level produced by 
apotransferrin alone, suggesting that lower concentration of 
CUSO4 may enhance growth, additional experiments including 
concentrations of CUSO4 as low as 10”^M, did not support a 
consistent growth effect at these lower concentrations. 
The effect of CrCl3 is presented in figures 13 and 14. 
There, too, it is evident that concentrations of this metal ion 
ranging from 10”^®- 10~^M had no significant effect on 
growth of Y-79 cells. 
In contrast to the other metals tested, Na2Se(>3, in the 
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presence of apotransferrin, clearly enhanced cell growth beyond the 
effect produced by apotransferrin alone. This effect appears at 
concentrations of 3xlO”^M Na2SeC>3 and below. (Figure 16). 
In an attempt to define the optimum concentration of Na2SeC>3, 
these experiments were repeated in the presence of lower 
concentrations of selenium. The effect appears to plateau at 
•*"10 -8 • «i3 10 -10 M selenium and by 10 M, growth enhancement 
disappears. 
1 < 
19 
FIGURE 1 
Seven day growth curve of Y-79 cells grown in the presence of 
RPMI-1640 + varying concentrations of C0CI2 without the addition 
of apotransferrin. The points designated "0" and "5%" refer to 
those cells grown without added C0CI2 or serum and those cells 
incubated in medium enriched with 51 fetal bovine serum 
respectively. Cells were fed on day 4. 
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FIGURE 2 
Effect of varying concentrations of C0CI2 on cell growth. The 
ratio of cell number at day 4 to cell number at day 1 is used as a 
measure of growth. The effect of RPMI-1640 enriched with 5% fetal 
bovine serum is also shown. 
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FIGURE 3 
Six day growth curve of Y-79 cells grown in the presence of 
RPMI-1640 + varying concentrations of CUSO4 without the addition 
of apotransferrin. The points designated "0" and "52" refer to 
those cells grown without added CUSO4 or serum and those cells 
incubated in medium enriched with 52 fetal bovine serum 
respectively. Cells were fed on day 4. 
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FIGURE 4 
Effect of varying concentrations of C11SO4 on cell growth. The 
ratio of cell number at day 3 to cell number at day 1 is used as a 
measure of growth. The effect of RPMI-1640 enriched with 5% fetal 
bovine serum is also shown. 
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FIGURE 5 
Seven day growth curve of Y-79 cells grown in the presence of 
RPMI-1640 + varying concentrations of CrCl3 without the addition 
of apotransferrin. The points designated "0" and "5%" refer to 
those cells grown without added CrCl3 or serum and those cells 
incubated in medium enriched with 51 fetal bovine serum 
respectively. Cells were fed on day 4. 
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FIGURE 6 
Effect of varying concentrations of CrCl3 on cell growth. The 
ratio of cell number at day 4 to cell number at day 1 is used as a 
measure of growth. The effect of RPMI-1640 enriched with 5% FBS 
is also shown. 
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FIGURE 7 
Seven day growth curve of Y-79 cells grown, in the presence of 
RPMI-1640 + varying concentrations of Na2Se03 without the 
addition of apotransferrin. The points designated "0" and "52" 
refer to those cells grown without added Na2Se03 or serum and 
those cells incubated in medium enriched with 5% fetal bovine serum 
respectively. Cells were fed on day 4. 
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FIGURE 8 
Effect of varying concentrations of Na2Se(>3 on cell growth. 
The ratio of cell number at day 4 to cell number at day 1 is used 
as a measure of growth. The effect of RPMI-1640 enriched with 51 
fetal bovine serum is also shown. 
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FIGURE 9 
Four day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml of 
apotransferrin + varying concentrations of C0CI2. The points 
designated "0" and "52" refer to those cells grown without added 
C0CI2, apotransferrin, or serum and those cells incubated in 
medium enriched with 5% fetal bovine serum respectively. "0 + trf" 
represents those cells grown in medium containing apotransferrin 
but devoid of C0CI2 or serum. 
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FIGURE 10 
Effect of varying concentrations of C0CI2 on cell growth in the 
presence of 3 ug/ml of apotransferrin. The ratio of cell number 
at day 4 to cell number at day 1 is used as a measure of growth. 
See figure 9 for an explanation of the symbols, "0", "5%" and "0 + 
trf ". 
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FIGURE 11 
Four day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml of 
apotransferrin + varying concentrations of CUSO4. The points 
designated "O" and "5%" refer to those cells grown without added 
C0CI2, apotransferrin, or serum and those cells incubated in 
medium enriched with 51 fetal bovine serum respectively. "0 + trf" 
represents those cells grown in medium containing apotransferrin 
but devoid of CUSO4 or serum. 
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FIGURE 12 
Effect of varying concentrations of C11SO4 on cell growth in the 
presence of 3 ug/ml of apotransferrin. The ratio of cell number at 
day 4 to cell number at day 1 is used as a measure of growth. See 
figure 11 for an explanation of the symbols, "0", "5%", and "0 + 
trf". 
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FIGURE 13 
Seven day growth curve of Y-79 cells grown in RPMI-1640 + 3 ug/ml 
of apotransferrin + varying concentrations of CrCl3„ The points 
designated "0" and "52" refer to those cell6 grown without added 
CrCl3, apotransferrin, or serum and those cells incubated in 
medium enriched with 52 fetal bovine serum respectively. "0 + trf" 
represents those cells grown in medium containing apotransferrin 
but devoid of CrCl3 or serum. Cells were fed on day A. 
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FIGURE 14 
Effect of varying concentrations of CrCl.3 on cell growth in the 
presence of 3 ug/ml of apotransferrin. The ratio of cell number at 
day 4 to cell number at day 1 is used as a measure of growth. See 
figure 13 for an explanation of the symbols, "0", "5%", and "0 + 
trf". 
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FIGURE 15 
Seven day growth curve of Y-79 cells grown in RPMX-1640 + 3 ug/ml 
of apotransferrin (trf) + varying concentrations of Na2SeQ3. 
The points designated "0" and "52" refer to those cells grown 
without added Na2Se03, trf, or serum and those cells incubated 
in medium enriched with 52 fetal bovine serum respectively. "0 + 
trf" represents those cells grown in medium containing trf but 
devoid of Na2Se03 or serum. Cells were fed on day 4. 
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FIGURE 16 
Effect of varying concentrations of Na2Se03 on cell growth in 
the presence of 3 ug/ml of apotransferrin. The ratio of cell 
number at day 4 to cell number at day 1 is used as a measure of 
growth. See figure 15 for an explanation of the symbols, "0", 
"5%", and "0 + trf". 
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Discussion 
These studies indicate that none of the four trace metals, 
tested in the absence of trasnferrin, were active in enhancing Y-79 
cell growth. In fact, the cobalt and copper ions, at the 
concentrations tested, appeared to be somewhat inhibitory for the 
first four days of the experiment. Perhaps, a trial of lower 
amounts of these ions might be justified in light of Ham's use of 
10"8M CuS04*5H20 and 10“9M CoC12*6H20 as 
optimum concentrations in his protein-free, synthetic medium, 
MCDB-301 (22). The ineffectiveness of the addition of cobalt may 
also be secondary to the presence of a minimal amount of vitamin 
b12 (0.005 mg/L) in RPMI-1640. Also, perhaps, the Y-79 cell line 
is unable to utilize inorganic cobalt or copper. 
The inability of chromium chloride to stimulate growth was not 
unexpected in light of present knowledge regarding the role of 
chromium in biological systems. Chromium has been studied 
extensively because it has long been known to be necessary for the 
maintenance of normal glucose tolerance in animals (31). However, 
chromium is biologically active in the form of an incompletely 
characterized group of complexes collectively known as "glucose 
tolerance factor". This factor is thought to operate by complexing 
with insulin and its tissue receptor and thereby facilitating 
insulin-receptor binding (40,38). Therefore, it is not surprising 
that chromium has never been found to be effective in the absence 
of insulin (39). Perhaps, a trial of chromium in the presence of 
insulin may unmask a growth potentiating effect of this metal in 
culture of Y-79 cells. 
Another difficulty remains, however. While inorganic chromium 
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is an effective dietary supplement for animals, the active form, 
the so-called glucose tolerance factor, has never been completely 
isolated. It is thought to contain trivalent chromium complexed 
vith nicotinic acid, glutamic acid, glycine, cysteine and traces of 
other amino acids (64). However, synthetic complexes of these 
molecules have been found to be less effective in lowering plasma 
concentrations of glucose and triglycerides than the glucose 
tolerance factor extracted from brewer's yeast (67). Therefore, 
adding inorganic chromium or even synthetic chromium complexes, as 
above, to Y-79 cell medium, even in the presence of adequate 
amounts of insulin, may not lead to enhanced growth (above that 
caused by insulin alone). Observation of the effect may have to 
await purification and characterization of the glucose tolerance 
factor. 
The failure of selenium to enhance growth is also not 
surprising because Y-79 cell stock cultures are maintained in 
medium containing 3xlO”^M Na2Se03. It probably takes far 
longer than the length of our experiments (7 days) for cells to 
become selenium depleted. Indeed, in the one available case report 
of a patient on total parenteral nutrition who developed selenium 
deficiency, the patient did not become symptomatic until about two 
years after beginning his course of hyperalimentation (31). Also, 
the in vitro studies of Rotruck et al. demonstrated that rat 
erythrocytes only become abnormally susceptible to hemolysis 36-39 
days after the rats begin receiving selenium deficient diets (52). 
Several years ago, our lab did some preliminary experiments which 
indicated that selenium enhanced the growth of Y-79 cells, and 
since that time, Na2Se03 has been added to the stock medium in 
- 
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an optimum concentration of 3x10 Perhaps, the lack of 
effect seen now is simply due to the longer time course necessary 
to deplete the stock cells of already present selenoenzymes, such 
as glutathione peroxidase (GSH-Px). Another trial of selenium with 
cells that had been grown in the absence of this metal for a more 
prolonged period would be useful to both confirm selenium's ability 
to enhance Y-79 cell growth as well as to elucidate the time course 
necessary to deplete the cells of selenium. 
The mechanism of the growth enhancing effect of transferrin 
remains unclear. Young et al. have noted a growth stimulating 
effect of transferrin on SV3T3 cells at an optimum concentration of 
10 °M but this effect is dependent on the presence of 100 
ng/ml of biotin (71). RPMI-1640 contains 200 ng/ml of biotin and 
perhaps, the effect of transferrin on Y-79 cells is also biotin 
dependent. Young et al. postulate that this effect may be 
secondary to unrelated metabolic events as their lab has also noted 
that biotin lowers the level of lactate secreted by SV3T3 cells 
(71). It would be interesting to see if the growth enhancing 
effect of transferrin on Y-79 cells is retained when biotin is 
deleted from the medium. 
We must also consider the possibility that Y-79 cells are 
producing a growth factor(s) which interacts with transferrin to 
provide a stimulus for cells to proliferate. Similar factors have 
been observed by Delarco and Todaro in transformed mouse cell lines 
and they term these agents "sarcoma growth factors" (8). This 
hypothesis is attractive in light of the growth permissive effect 
of medium, conditioned by Y-79 cells, on untransformed retinal 
cells. 
■ 
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The presence of transferrin receptors on the surfaces of human 
lymphoblastoid and other malignant cell lines has been noted by 
Galbraith et al. (13). They hypothesize that transferrin 
receptors are used by these cells to bind host protein and thereby 
hide cell-specific antigens from the host immune system. This 
immunosurveillance theory is probably not an important 
consideration under tissue culture conditions. However, tumor 
receptors for transferrin could still be important intermediaries 
for transferrin's growth effect in vitro. Therefore, a 
demonstration of the presence of apotransferrin receptors on the 
surface of Y-79 cells would certainly be of interest. 
It is unlikely that the growth effect of transferrin can be 
explained simply in terms of supplying the iron requirement of Y-79 
cells since apotransferrin was used in all of our experiments. 
However, it is possible that traces of iron salts contaminated our 
transferrin preparation and provided Y-79 cells with a critical 
element. We are planning to assay our apotransferrin for the 
presence of iron to help clarify this possibility. It would also 
be interesting to see if growth effects could be duplicated with 
other organic iron compounds such as hemoglobin or transferrin from 
other species, or even, inorganic iron salts. 
Perhaps, transferrin plays a role in transporting other 
crucial metallic cations besides iron. The consistently greater 
growth achieved by cells incubated in serum enriched medium 
compared to cells grown in transferrin enriched medium might be 
explained by the presence of these trace metals in serum. Perhaps, 
the growth enhancing effect of transferrin could be explained, and 
indeed, increased to the levels achieved by cells grown in the 
' 
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presence of serum by adding certain trace metals to the medium. 
Our studies were aimed at examining several likely candidates, 
including copper, cobalt, chromium and selenium. 
As shown in the results, copper, cobalt and chromium had no 
significant effects on Y-79 cell growth. These observations were 
somewhat surprising since these three essential metals are all 
known to bind to transferrin (23) and therefore, one might 
conjecture that transferrin could increase their availability to 
cells. The unlikely possibility also exists that these metals, 
required in trace amounts, are already present as contaminants in 
saturating amounts, and therefore, no effect is seen with the 
addition of even larger amounts. 
The most intriguing observation of this study is the effect of 
selenium and transferrin on the growth of Y-79 cells. Although 
transferrin alone had a small growth enhancing effect on Y-9 cells, 
the addition of selenium and transferrin resulted in far greater 
growth than that achieved by cells grown in transferrin alone. The 
explanation for this effect is unclear. However, a related 
observation comes from the work of Rodvien et al. (51). They 
noted that rabbit erythrocyte GSH-Px activity was markedly 
decreased by the induction of iron deficiency anemia whereas anemia 
secondary to massive phlebotomy or administration of intra- 
peritoneal phenylhydrazine did not lead to changes in enzyme 
activity. Also, during the induction of iron deficiency, 
reticulocytes had lower enzyme activity than the older erythrocytes 
while during the iron repletion phase, the opposite was observed. 
Other enzymes, such as glutathione reductase, maintained constant 
activities throughout the experiments. They conjecture that iron 
- 
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may be necessary for the synthesis of GSH-Px or perhaps, that this 
enzyme requires an iron containing protein as a coenzyme or 
electron carrier. Therefore, in our studies, transferrin may be 
acting in an iron transport capacity, providing Y-79 cells with 
enough iron to incorporate the available selenium into GSH-Px and 
thus protect the cell membranes from oxidation. However, as the 
extent of selenium binding to transferrin is unknown, we cannot be 
certain that transferrin does not play a more direct role. 
Perhaps, it enables the cell to transport selenium more 
efficiently, thereby making it more available for GSH-Px synthesis, 
itself stimulated by the increased concentration of selenium (16). 
While selenium alone enhances growth when added to Y-79 cells 
which have been incubated in selenium deficient medium for a 
prolonged period (past unpublished experiments), our current 
experiments do not reveal a growth enhancing effect of selenium 
when it is added alone to cells previously maintained in selenium 
enriched medium. Therefore, as discussed earlier, it is probable 
that certain selenoproteins are not seriously depleted within one 
week of incubation in selenium free medium. However, the 
enhancement of growth seen when cells are incubated in the presence 
of selenium and apotransferrin occurs within several days of the 
beginning of the experiment (Figures 15 and 16). Therefore, it 
remains unclear that this effect of selenium is, in fact, 
dependent on its incorporation into selenoproteins. Alternatively, 
selenium could be incorporated into different selenoproteins in the 
presence of apotransferrin. Perhaps, transferrin increases 
selenium's availability to Y-79 cells and/or its intracellular 
concentration enabling them to synthesize other important 
. 
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selenoenzymes. Of course, tranferrin, itself, acting as a growth 
factor, could be directly responsible for activating a selenium 
dependent system. Further experiments should include observations 
of the growth effect of apotransferrin in cells that have been 
depleted of selenium over a prolonged period in order to ascertain 
that transferrin is active alone as a growth promoting agent. 
Also, elucidation of a connection between transferrin and selenium 
systems will depend on further studies of transferrin and selenium 
binding as well as GSH-Px activity in the Y-79 cell line. 
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